Stock 4130 GENOVATE BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Genovate Biotechnology Co., Ltd.

Equities

4130

TW0004130000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
24.45 TWD +0.41% Intraday chart for Genovate Biotechnology Co., Ltd. +2.30% -8.08%
Mar. 28 Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Genovate Biotechnology Co., LTD. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of pharmaceutical preparations, drug substances and intermediates. The Company's products include nervous system drugs, digestive system drugs, analgesic and anti-inflammatory drugs, urogenital system drugs, antimicrobial drugs, cardiovascular system drugs, acne drugs, antineoplastic drugs and anti-diabetic drugs, as well as healthcare food and cosmetics. The Company is also engaged in the provision of clinical experimental testing services and technology export services. The Company distributes its products mainly within domestic market.

Number of employees: 199

Sales per Business

TWD in Million2022Weight2023Weight Delta
Pharmaceutical Manufacturing
98.2 %
414 94.3 % 519 98.2 % +25.47%
Technical Service
0.9 %
5 1.2 % 5 0.9 % -11.29%
Other
0.8 %
0 0.0 % 4 0.8 % +4,966.28%
Agency
0.1 %
20 4.5 % 0 0.1 % -98.04%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
98.3 %
435 99.2 % 519 98.3 % +19.33%
Others
1.7 %
4 0.8 % 9 1.7 % +158.64%

Managers

Managers TitleAgeSince
Chia Chen Chu CEO
 Chief Executive Officer - 17-06-22
Hui ling Lin DFI
 Director of Finance/CFO - 09-03-31
Cheng Chen CHM
 Chairman 69 93-02-13
Wei Min Chiang ADM
 Chief Administrative Officer - 98-04-15
Ming Kuei Peng SAM
 Sales & Marketing - 05-12-31

Members of the board

Members of the board TitleAgeSince
Cheng Chen CHM
 Chairman 69 93-02-13
Howard Lee BRD
 Director/Board Member 62 14-06-09
Ko Yi Liu BRD
 Director/Board Member 58 17-05-31
Te Jen Liu BRD
 Director/Board Member - 95-11-19
Chia Chen Chu CEO
 Chief Executive Officer - 17-06-22
Chun Mao Lin BRD
 Director/Board Member - 95-11-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 109,376,000 76,120,851 ( 69.60 %) 0 69.60 %

Shareholders

NameEquities%Valuation
Dimensional Fund Advisors Ltd.
0.0217 %
23,726 0.0217 % 18 534 NT$
DFA Australia Ltd.
0.001418 %
1,551 0.001418 % 1 212 NT$

Company contact information

Genovate Biotechnology Co., Ltd.

Hsinchu Industrial Park No. 1, Industrial 1st Road

302 41, Hsinchu

+

http://www.genovate-bio.com
address Genovate Biotechnology Co., Ltd.(4130)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
GENOVATE BIOTECHNOLOGY CO., LTD. Stock Genovate Biotechnology Co., Ltd.
-8.08% 82M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.66% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.45% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.90% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.62% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.81% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4130 Stock
  4. Company Genovate Biotechnology Co., Ltd.